VVUS: VIVUS INC. (NASDAQ) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Early Out who wrote (9190)	6/4/1998 11:14:00 PM
From: VLAD	Read Replies (1) of 23519

John, I can't argue with anything you said--agree with all points. I guess part of my problem is that I bought it as a value play thinking that a company with an approved product and unique delivery system would not be trading below its IPO four years ago. I was looking for a 12 to 18 month play. Every product reaches its saturation point in the market. I could be wrong but I think their is still room for substantial growth if we include the entire world as the larger sandbox. I also considered that our over 40 population is growing every year meaning that there will always be new patients produced with time. Also, I thought that the 7 year patent on the delivery system was worth more than 6 5/16 a share. With the latest concern regarding cardiac failure and Viagra I think many doctors with ED patients of vascular origin will be reluctant to prescribe Viagra (there are just too many liability issues involved). If all the ED publicity makes the sandbox much bigger in the states and Viagra is avoided in many of the vascular patients, I think that the MUSE nitche will be greater than before Viagra was released.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next